BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 32156236)

  • 1. 1,3,5-Triazine-azole Hybrids and their Anticancer Activity.
    Guo H; Diao QP
    Curr Top Med Chem; 2020; 20(16):1481-1492. PubMed ID: 32156236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isatin-azole hybrids and their anticancer activities.
    Hou Y; Shang C; Wang H; Yun J
    Arch Pharm (Weinheim); 2020 Jan; 353(1):e1900272. PubMed ID: 31691360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moxifloxacin-isatin Hybrids Tethered by 1,2,3-triazole and their Anticancer Activities.
    Yang M; Liu H; Zhang Y; Wang X; Xu Z
    Curr Top Med Chem; 2020; 20(16):1461-1467. PubMed ID: 31994464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent updates on 1,2,3-, 1,2,4-, and 1,3,5-triazine hybrids (2017-present): The anticancer activity, structure-activity relationships, and mechanisms of action.
    Dong G; Jiang Y; Zhang F; Zhu F; Liu J; Xu Z
    Arch Pharm (Weinheim); 2023 Mar; 356(3):e2200479. PubMed ID: 36372519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of mono-and di-pyrazolyl-s-triazine derivatives, their anticancer profile in human cancer cell lines, and in vivo toxicity in zebrafish embryos.
    Farooq M; Sharma A; Almarhoon Z; Al-Dhfyan A; El-Faham A; Taha NA; Wadaan MAM; Torre BG; Albericio F
    Bioorg Chem; 2019 Jun; 87():457-464. PubMed ID: 30927586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in isatin hybrids as potential anticancer agents.
    Ding Z; Zhou M; Zeng C
    Arch Pharm (Weinheim); 2020 Mar; 353(3):e1900367. PubMed ID: 31960987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of the Synthesis and Anticancer Properties of Pyrazolo[4,3-
    Bernat Z; Szymanowska A; Kciuk M; Kotwica-Mojzych K; Mojzych M
    Molecules; 2020 Aug; 25(17):. PubMed ID: 32872493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview on the recent developments of 1,2,4-triazine derivatives as anticancer compounds.
    Cascioferro S; Parrino B; Spanò V; Carbone A; Montalbano A; Barraja P; Diana P; Cirrincione G
    Eur J Med Chem; 2017 Dec; 142():328-375. PubMed ID: 28851503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hybrid Molecules Composed of 2,4-Diamino-1,3,5-triazines and 2-Imino-Coumarins and Coumarins. Synthesis and Cytotoxic Properties.
    Makowska A; Sączewski F; Bednarski PJ; Sączewski J; Balewski Ł
    Molecules; 2018 Jul; 23(7):. PubMed ID: 29970833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, antitumor evaluation and microarray study of some new pyrazolo[3,4-d][1,2,3]triazine derivatives.
    Nasr T; Bondock S; Youns M; Fayad W; Zaghary W
    Eur J Med Chem; 2017 Dec; 141():603-614. PubMed ID: 29107422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and in vitro anticancer evaluation of some 4,6-diamino-1,3,5-triazine-2-carbohydrazides as Rad6 ubiquitin conjugating enzyme inhibitors.
    Kothayer H; Spencer SM; Tripathi K; Westwell AD; Palle K
    Bioorg Med Chem Lett; 2016 Apr; 26(8):2030-4. PubMed ID: 26965855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1,3,5-Triazines: A promising scaffold for anticancer drugs development.
    Cascioferro S; Parrino B; Spanò V; Carbone A; Montalbano A; Barraja P; Diana P; Cirrincione G
    Eur J Med Chem; 2017 Dec; 142():523-549. PubMed ID: 29046238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, Structure and Antiproliferative Activity of New pyrazolo[4,3- e]triazolo[4,5-b][1,2,4]triazine Derivatives.
    Mojzych M; Tarasiuk P; Karczmarzyk Z; Juszczak M; Rzeski W; Fruzinski A; Wozny A
    Med Chem; 2018; 14(1):53-59. PubMed ID: 29065838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Di- and tri-substituted s-triazine derivatives: Synthesis, characterization, anticancer activity in human breast-cancer cell lines, and developmental toxicity in zebrafish embryos.
    El-Faham A; Farooq M; Almarhoon Z; Alhameed RA; Wadaan MAM; de la Torre BG; Albericio F
    Bioorg Chem; 2020 Jan; 94():103397. PubMed ID: 31706684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and Characterization of New Series of 1,3-5-Triazine Hydrazone Derivatives with Promising Antiproliferative Activity.
    H Al Rasheed HHA; M Malebari AM; A Dahlous KA; El-Faham A
    Molecules; 2020 Jun; 25(11):. PubMed ID: 32545272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uses of cyclohexane-1,3-dione for the synthesis of 1,2,4-triazine derivatives as anti-proliferative agents and tyrosine kinases inhibitors.
    Megally Abdo NY; Milad Mohareb R; Halim PA
    Bioorg Chem; 2020 Apr; 97():103667. PubMed ID: 32087416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, structural characterization and antitumor activity of novel 2,4-diamino-1,3,5-triazine derivatives.
    Brzozowski Z; Saczewski F; Gdaniec M
    Eur J Med Chem; 2000 Dec; 35(12):1053-64. PubMed ID: 11248404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triazine as a promising scaffold for its versatile biological behavior.
    Singla P; Luxami V; Paul K
    Eur J Med Chem; 2015 Sep; 102():39-57. PubMed ID: 26241876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticancer potential of cardiac glycosides and steroid-azole hybrids.
    Hou Y; Shang C; Meng T; Lou W
    Steroids; 2021 Jul; 171():108852. PubMed ID: 33887267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of 5,6-diaryl-1,2,4-triazines hybrids as potential apoptosis inducers.
    Fu DJ; Song J; Hou YH; Zhao RH; Li JH; Mao RW; Yang JJ; Li P; Zi XL; Li ZH; Zhang QQ; Wang FY; Zhang SY; Zhang YB; Liu HM
    Eur J Med Chem; 2017 Sep; 138():1076-1088. PubMed ID: 28763643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.